Cutaneous Lupus Erythematosus (CLE) Latest Advances
Find the Latest Research About Cutaneous Lupus Erythematosus (CLE)
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6729 publications
Drug-Induced Subacute Cutaneous Lupus Erythematosus.
Journal: The New England journal of medicine
Published: August 18, 2026
Isoniazid-induced seronegative cutaneous lupus in a patient with lupus vulgaris.
Journal: JAAD case reports
Published: August 16, 2026
Transforming the treatment of autoimmune skin diseases: a journey through biologic therapies.
Journal: Expert opinion on biological therapy
Published: August 13, 2026
Pediatric linear cutaneous lupus mimicking lichen striatus.
Journal: JAAD case reports
Published: August 08, 2026
The Ethical Role of Dermatologists in Smoking Cessation Counseling.
Journal: Clinics in dermatology
Published: August 07, 2026
Placebo Response in Randomised Controlled Trials of Systemic Therapies for Cutaneous Lupus Erythematosus: A Systematic Review and Meta-Analysis.
Journal: Pharmaceutical medicine
Published: July 28, 2026
Increased risk of cutaneous lupus erythematosus flare during the late menopausal transition: A retrospective study of 64 women.
Journal: JAAD international
Published: July 12, 2026
Profiling Immune-Related Adverse Events Associated with Imatinib: A Two-Decade Real-World Safety Study Based on FDA Adverse Event Reporting System.
Journal: Cancer investigation
Published: July 05, 2026
Maintenance of clinical response to anifrolumab in cutaneous lupus erythematosus after dose spacing.
Maintenance of clinical response to anifrolumab in cutaneous lupus erythematosus after dose spacing.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: July 02, 2026
Maintenance of clinical response to anifrolumab in cutaneous lupus erythematosus after dose spacing.
Maintenance of clinical response to anifrolumab in cutaneous lupus erythematosus after dose spacing.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: July 02, 2026
TRAF3IP2 (Act1/CIKS) variants: A domain to phenotype framework and therapeutic implications.
Journal: Cytokine & growth factor reviews
Published: June 29, 2026
Last Updated: 09/26/2026